CAPPED BONUSZERTIFIKAT - ABBOTT LABORATORIES Stock

Certificat

DE000PG1DY97

Market Closed - Bid/Ask 03:04:18 2024-06-28 am EDT After market 02:46:17 pm
86.99 EUR -0.09% Intraday chart for CAPPED BONUSZERTIFIKAT - ABBOTT LABORATORIES 86.82 -0.20%
Current month+2.79%
1 month+2.33%
Date Price Change
24-06-28 86.99 -0.09%
24-06-27 87.07 -0.16%
24-06-26 87.21 +0.39%
24-06-25 86.87 -0.16%
24-06-24 87.01 -0.06%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 03:04 am EDT

More quotes

Static data

Product typeCertificati Bonus e Protezione parz.
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PG1DY9
ISINDE000PG1DY97
Date issued 2024-05-23
Strike 100 $
Maturity 2025-06-20 (357 Days)
Parity 1 : 1
Emission price 82.59
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 87.21
Lowest since issue 84.35
Spread 0.05
Spread %0.06%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104.6 USD
Average target price
125.2 USD
Spread / Average Target
+19.60%
Consensus